Comprehensive Psychiatry
Volume 43, Issue 4 , Pages 311-318 , July 2002

Symptom trajectories in psychotic episodes

  • Zeno Kupper
    • ,
  • Wolfgang Tschacher

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Zeno Kupper, Ph.D., University of Bern, University Hospital of Social and Community Psychiatry, Laupenstrasse 49, PO Box 52, CH-3010 Bern, Switzerland.

References 

  1. Wittchen HU, Lieb R, Pfister H, Schuster P. The waxing and waning of mental disorders: evaluating the stability of syndromes of mental disorders in the population. Compr Psychiatry. 2000;41:122–132
  2. Globus GG, Arpaia JP. Psychiatry and the new dynamics. Biol Psychiatry. 1994;35:352–364
  3. Aebi E, Ackermann K, Revenstorf D. Ein Konzept der sozialen Unterstützung für akut Schizophrene. Zeitreihenanalysen täglicher Fluktuationen psychotischer Merkmale. Z Klin Psychol Psychopathol Psychother. 1993;41:18–30
  4. Hoffmann H, Kupper Z. Patient dynamics in early stages of vocational rehabilitation: a pilot study. Compr Psychiatry. 1996;37:216–221
  5. Kupper Z. Dynamische Modelle für chronische psychische Störungen. Lengerich, Germany: Pabst Science Publishers; 1999;
  6. Kupper Z, Hoffmann H. Course patterns of psychosocial functioning in schizophrenia patients attending a vocational rehabilitation program. Schizophr Bull. 2000;26:681–698
  7. Tschacher W. The dynamics of psychosocial crises: time courses and causal models. J Nerv Ment Dis. 1996;184:172–179
  8. Tschacher W, Scheier Ch, Hashimoto Y. Dynamical analyses of schizophrenia courses. Biol Psychiatry. 1997;41:428–437
  9. Flechtner KM, Steinacher B, Mackert A. Subthreshold symptoms and vulnerability indicators (e.g., eye tracking dysfunction) in schizophrenia. Compr Psychiatry. 2000;41:86–89
  10. Buckley PF, Hasan S, Friedman L, Cerny C. Insight and schizophrenia. Compr Psychiatry. 2001;42:39–41
  11. Penades R, Gasto C, Boget T, Catalan R, Salamero M. Deficit in schizophrenia: The relationship between negative symptoms and neurocognition. Compr Psychiatry. 2001;42:64–69
  12. Cuesta MJ, Peralta V. Psychopathological dimensions in schizophrenia. Schizophr Bull. 1995;21:473–482
  13. Brekke JS, Debonis JA, Graham JW. A latent structure analysis of the positive and negative symptoms in schizophrenia. Compr Psychiatry. 1994;35:252–259
  14. Lenzenweger MF, Dworkin RH. The dimensions of schizophrenia phenomenology. Not one or two, at least three, perhaps four. Br J Psychiatry. 1996;168:432–440
  15. Mcgorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med. 1998;28:935–947
  16. Peralta V, Cuesta MJ. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr Res. 1999;38:13–26
  17. Eaton WW, Thara R, Federman B, Melton B, Liang KY. Structure and course of positive and negative symptoms in schizophrenia. Arch Gen Psychiatry. 1995;52:127–134
  18. Carpenter WT, Heinrichs DW, Alphs LD. Treatment of negative symptoms. Schizophr Bull. 1985;11:440–452
  19. Häfner H, Maurer K. Are there two types of schizophrenia? True onset and sequence of positive and negative syndromes prior to first admission. In:  Marneros A,  Andreasen NC,  Tsuang MT editor. Negative Versus Positive Schizophrenia. Berlin, Germany: Springer; 1991;p. 134–159
  20. Gaebel W, Janner M, Frommann N, Pietzcker A, Kopcke W, Linden M, et al.  Prodromal states in schizophrenia. Compr Psychiatry. 2000;41:76–85
  21. Moller P. First-episode schizophrenia: do grandiosity, disorganization, and acute initial development reduce duration of untreated psychosis? An exploratory naturalistic case study. Compr Psychiatry. 2000;41:184–190
  22. Czobor P, Volavka J. Positive and negative symptoms: is their change related?. Schizophr Bull. 1996;22:577–590
  23. Garver DL, Holcomb JA, Christensen JD. Heterogeneity of response to antipsychotics from multiple disorders in the schizophrenia spectrum. J Clin Psychiatry. 2000;61:964–972
  24. Tandon R, Dequardo JR, Taylor SF, Mcgrath M, Jibson M, Eiser A, et al.  Phasic and enduring negative symptoms in schizophrenia: biological markers and relationship to outcome. Schizophr Res. 2000;45:191–201
  25. Ciompi L, Kupper Z, Aebi E, Dauwalder JP, Hubschmid T, Trütsch K, et al.  Das Pilot-Projekt “Soteria Bern” zur Behandlung akut Schizophrener. II. Ergebnisse der vergleichenden prospektiven Verlaufsstudie über zwei Jahre. Nervenarzt. 1993;64:440–450
  26. Tschacher W, Baur N. Wirkungsgefüge von Psychosen I. Switzerland: University Hospital of Social and Community Psychiatry, University of Bern,; 1996; Research Report 96-1
  27. Tschacher W, Baur N, Kupper Z. Wirkungsgefüge von Psychosen II. Switzerland: University Hospital of Social and Community Psychiatry, University of Bern,; 2000; Research Report 00-1
  28. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420–428
  29. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–276
  30. Institute Inc SAS. SAS/ETS User's Guide, Version 6. Ed. 2. Cary, NC: SAS Institute; 1993;
  31. Peralta V, Cuesta MJ. How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res. 2001;49:269–285

PII: S0010-440X(02)00007-X

doi: 10.1053/comp.2002.33501

Comprehensive Psychiatry
Volume 43, Issue 4 , Pages 311-318 , July 2002

Article Tools